Drug Analytical Research

作者必须在稿件的“方法”部分添加声明，公开任何生成式人工智能或AI辅助技术在稿件撰写中的使用；除非属于正式研究设计的一部分，否则不鼓励使用AI生成的内容，且未清晰说明工具名称的AI内容不被允许。 模型中文摘要

Authors must publicize any use of generative AI and AI-assisted technologies in the elaboration of manuscript by adding a statement within the Methods section of their manuscript. Content created by artificial intelligence is discouraged, unless part of formal research design and is not permitted without clear description of the name of the tool.

作者在投稿时须披露每位作者的潜在竞争利益（包括专利所有权、咨询费、演讲费、公司雇佣等财务或商业利益）；如无竞争利益，应写明“作者声明本文无相关利益冲突”，所有披露内容将置于稿件末尾的“利益冲突”部分。 模型中文摘要

Authors are required to disclose any potential competing interests during submission. This includes financial or commercial interests (e.g., patent ownership, consulting fees, speaker fees, employment with a company). This disclosure should be made for each author. If no competing interests exist, the following statement should be included: "The authors declare no conflicts of interest related to …

在此填写的姓名和地址仅用于本出版物提供的服务，不会用于其他目的或提供给第三方。 模型中文摘要

Names and addresses informed here will be used exclusively for the services provided by this publication, and will not be made available for other purposes or to third parties.

任何涉及人类或动物的实验研究都必须证明已事先获得相应机构审查机构的伦理批准。 模型中文摘要

Every experimental study on humans or animals must be proven to have the prior ethics approval of the appropriate institutional review body.

已发表论文的版权持有者为Drug Analytical Research；作者可另行签订非排他性分发合同（如存入机构知识库或出版成书），但须注明首次发表于本刊；许可协议为CC BY-NC-SA 4.0，允许用户在无需事先许可的情况下阅读、下载、复制、分发、打印、检索或链接文章全文，或将其用于其他合法目的。 模型中文摘要

The Copyright holder of manuscripts published is Drug Analytical Research. Authors who publish with this journal are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journ…

投稿的原创和综述文章将由该领域两位知名研究者进行单盲同行评审；评审标准优先考虑创新性、原创性、相关性以及稿件对科学界的贡献；审稿人自投稿之日起最多有30天时间提供反馈。 模型中文摘要

Submitted original and review articles will undergo evaluation by two prominent researchers recognized in the field, in single-blind peer review. The evaluation criteria prioritize innovation, originality, relevance, and the contribution of the manuscript to the scientific community. Reviewers are given up to 30 days from submission to provide their feedback.